This book provides a comprehensive overview of botulinum toxin therapy in common childhood disorders, including migraine, bladder dysfunction, dystonia, neuropathic pain, and cerebral palsy. It covers 12 major clinical areas in which botulinum toxin can help alleviate disabling symptoms in pediatric populations. The book is intended for neurologists, neurotoxicologists, and scientists working in the field of botulinum toxins.

Bahman Jabbari, MD, FAAN is Professor Emeritus of Neurology at Yale University School of Medicine. He is an internationally recognized expert in botulinum neurotoxin research and its clinical applications. His work has focused on elucidating the diverse synaptic mechanisms underlying botulinum toxin action and translating these insights into therapeutic strategies. Dr. Jabbari has extensive clinical and research experience in movement disorders, including Parkinson’s disease, dystonia, tremor, and restless legs syndrome, as well as in the use of botulinum toxin for a wide range of neurological and non-neurological conditions. He has authored numerous peer-reviewed publications and book chapters and is widely regarded as a leader in the field of neurotherapeutics.

Sanaz Attaripour Isfahani, MD, FAAN is a Clinical Associate Professor of Neurology at the University of California, Irvine, and a movement disorders specialist with expertise in ataxia and neurodegenerative diseases. Her work integrates clinical care, translational research, and innovative approaches to neurological disorders, including the use of botulinum toxin in complex patient populations. Dr. Attaripour has a strong interest in digital biomarkers, clinical trial development, and advancing patient-centered care in movement disorders. She is actively involved in mentoring trainees and leading multidisciplinary initiatives aimed at improving outcomes for patients with neurological conditions. Her work reflects a commitment to bridging scientific innovation with practical clinical applications.